ARJUN TARAKAD to Treatment Outcome
This is a "connection" page, showing publications ARJUN TARAKAD has written about Treatment Outcome.
Connection Strength
0.052
-
Safety, tolerability, and efficacy of NLY01 in early untreated Parkinson's disease: a randomised, double-blind, placebo-controlled trial. Lancet Neurol. 2024 01; 23(1):37-45.
Score: 0.018
-
Interactive mobile application for Parkinson's disease deep brain stimulation (MAP DBS): An open-label, multicenter, randomized, controlled clinical trial. Parkinsonism Relat Disord. 2023 04; 109:105346.
Score: 0.017
-
Association of clinical outcomes and connectivity in awake versus asleep deep brain stimulation for Parkinson disease. J Neurosurg. 2023 04 01; 138(4):1016-1027.
Score: 0.016